- Home
- JMIA vs NVCR Comparison
JMIA vs NVCR Comparison
Compare JMIA & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JMIA | NVCR |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Germany | Switzerland |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | JMIA | NVCR |
|---|---|---|
| Price | $14.26 | $14.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $17.00 | ★ $28.42 |
| AVG Volume (30 Days) | ★ 3.1M | 1.5M |
| Earning Date | 02-12-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $173,224,000.00 | ★ $642,269,000.00 |
| Revenue This Year | $20.96 | $9.75 |
| Revenue Next Year | $22.42 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $1.60 | $10.70 |
| 52 Week High | $13.92 | $30.78 |
Technical Indicators
Market Signals| Indicator | JMIA | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 65.38 |
| Support Level | $11.48 | $12.88 |
| Resistance Level | $13.55 | $13.64 |
| Average True Range (ATR) | 0.72 | 0.50 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 92.36 | 95.83 |
Price Performance
Historical ComparisonAbout JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.